Phase 1 Trial of AUC-Targeted Melphalan in Myeloma Patients Undergoing Autologous Transplant (The MyMel Study)
- Resource Type
- Source
- Transplantation and Cellular Therapy. 29:S168-S169
- Subject
Transplantation Molecular Medicine Immunology and Allergy Cell Biology Hematology - Language
- ISSN
- 2666-6367